These efforts have defined tissue-specific consensus PR binding sites and identified specific genes modulated by application of the synthetic antiprogestin mifepristone in primary cultures derived from uterine leiomyomas (13). The gene discussed is PGR; the disease is uterine corpus leiomyoma.